Fig. 2From: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trialProportion of hospitalization-free survival time HR: hazard ratio; 95% CI: 95% confidence intervalBack to article page